Treatment Action Group (TAG) and I congratulate SR UN Special Rapporteur Cultural Rights on a brilliant report on participation and the right to science. This report holds many lessons that are essential to #TBrights and #communityleadership .

morning pages. the report's 18th year and my 11th. (how?) still proofreading by hand.

coming Dec. 5th (I hope)

We were appalled by info uncovered by rigorous @ProPublica reporting on how GSK has impeded progress on a desperately needed TB vaccine. Our response gives an overview of the revelations & outlines what we urge GSK, US Government + Gates MRI to do next: treatmentactiongroup.org/statement/tag-…

At the #UNHLM on TB, Marisol Touraine emphasized accessibility over profits, urging pharma to abandon secondary patents. With Unitaid's leadership, joint efforts can make a difference.

Dive in: unitaid.org/news-blog/unit…

returning to this platform to say: to acknowledge when a company does a 'right thing' (though why didn't they from the start?) does not require fawning praise

as an Okie, I am thinking today of what JNJ did to my home oag.ok.gov/articles/after…

I reserve judgment until I see more

Hi, @JNJGlobalHealth. Here you can clearly see, even if via meme, that you did NOT fund the majority of bedaquiline research. It was mostly funded by the public. You've had the patent for 20 years. That's enough. Pledge not to enforce secondary patents in nations with a high TB…

An open letter to Johnson & Johnson. Stop pursuing the secondary patent of bedaquiline. YOU KNOW that millions of people will be unable to access lifesaving treatment for multidrug-resistant tuberculosis if you extend the patent. YOU KNOW it violates your credo. youtube.com/watch?v=tMhgw5…

The Global TB CAB is thrilled Gates Foundation + Wellcome will fund Phase 3 trials for M72/AS01E TB vaccine candidate. But Chair Patrick Agbassi urges the inclusion of often neglected groups at risk of TB in R&D process.

More info: prnewswire.com/news-releases/…

We did it! In a landmark verdict, the Indian Patent Office rejected Johnson and Johnson’s patent application that would have extended the monopoly on key anti-TB drug #Bedaquiline ! @ptisile and I – both of us TB survivors -- had filed pre-grant opposition against the application

Under the Unitaid-funded #IMPAACT4TB project, Treatment Action Group (TAG) is the lead partner in supporting global and national advocacy by civil society and community-based organizations to scale-up TB preventative treatment and pediatric #TB interventions.

➡️ youtube.com/watch?v=I1Jd6m…

For the first time ever, global TB R&D funding reached US$1 billion in 2021 – yet funding for TB vaccines received only $0.12 of every dollar that went to TB research.

Thread on #TBvax insights from the new Treatment Action Group (TAG) & Stop TB Partnership report 🧵⬇️ (1/) treatmentactiongroup.org/resources/tbrd…

For the first time in history, global TB R&D funding reached $1 billion in 2021 – a milestone made possible by sustained advocacy, but which nonetheless falls short of what’s needed to end TB.

Thread on the new report from TAG + Stop TB Partnership: treatmentactiongroup.org/resources/tbrd…

Nice piece in Spotlight covering noteworthy clinical trial results presented at The Union Conference: Shorter TB regimens could be on the horizon, but key research gaps remain.

Featuring TAG TB Co-Director Lindsay McKenna:
spotlightnsp.co.za/2022/11/15/tb-…

The use of X-Ray screening for lung scars to diagnose current or prior TB and use any scarring to deny visa to countries is unscientific and a violation of the #righttohealth and #righttoscience Treatment Action Group (TAG) documented this practice in the UAE in 2018. treatmentactiongroup.org/letter/tb-huma…